| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.931 | 0 | 0.931 | Progesterone agonist | 0.895 0 DBMET02127 0.41 0.001 DBMET02128 0.818 0.001 DBMET02129 0.818 0.001 DBMET02130 0.307 0.002 DBMET02131 0.792 0.001 DBMET02132 | ||
| 0.855 | 0.009 | 0.945 | Antiinflammatory | 0.872 0.007 DBMET02127 0.878 0.007 DBMET02128 0.872 0.007 DBMET02129 0.872 0.007 DBMET02130 0.803 0.015 DBMET02131 0.945 0.005 DBMET02132 | DBMET02132 | |
| 0.796 | 0.002 | 0.796 | Androgen antagonist | 0.709 0.003 DBMET02127 0.796 0.002 DBMET02128 0.687 0.003 DBMET02129 0.687 0.003 DBMET02130 0.725 0.003 DBMET02131 0.77 0.002 DBMET02132 | ||
| 0.798 | 0.011 | 0.828 | Caspase 9 stimulant | 0.72 0.021 DBMET02127 0.806 0.01 DBMET02128 0.828 0.008 DBMET02129 0.828 0.008 DBMET02130 0.81 0.01 DBMET02131 0.747 0.018 DBMET02132 | DBMET02130 | |
| 0.77 | 0.015 | 0.856 | Transcription factor NF kappa B inhibitor | 0.775 0.015 DBMET02127 0.751 0.016 DBMET02128 0.82 0.011 DBMET02129 0.82 0.011 DBMET02130 0.856 0.009 DBMET02131 0.75 0.016 DBMET02132 | DBMET02131 | |
| 0.723 | 0.001 | 0.723 | Progesterone antagonist | 0.539 0.002 DBMET02127 0.427 0.003 DBMET02128 0.401 0.003 DBMET02129 0.401 0.003 DBMET02130 0.64 0.002 DBMET02131 0.564 0.002 DBMET02132 | ||
| 0.709 | 0.002 | 0.865 | Aromatase inhibitor | 0.602 0.003 DBMET02127 0.592 0.003 DBMET02128 0.522 0.003 DBMET02129 0.522 0.003 DBMET02130 0.865 0.001 DBMET02131 0.579 0.003 DBMET02132 | DBMET02131 | |
| 0.681 | 0.001 | 0.681 | Lipocortins synthesis antagonist | 0.645 0.002 DBMET02127 0.558 0.003 DBMET02128 0.628 0.002 DBMET02129 0.628 0.002 DBMET02130 0.549 0.003 DBMET02131 0.622 0.002 DBMET02132 | ||
| 0.699 | 0.031 | 0.736 | Apoptosis agonist | 0.709 0.029 DBMET02127 0.656 0.038 DBMET02128 0.736 0.025 DBMET02129 0.736 0.025 DBMET02130 0.725 0.027 DBMET02131 0.657 0.038 DBMET02132 | DBMET02130 | |
| 0.64 | 0.005 | 0.64 | Hypoxia-inducible factor 1 alpha inhibitor | 0.423 0.025 DBMET02127 0.371 0.038 DBMET02128 0.5 0.015 DBMET02129 0.5 0.015 DBMET02130 0.519 0.013 DBMET02131 0.414 0.027 DBMET02132 | ||
| 0.547 | 0.021 | 0.607 | Immunosuppressant | 0.554 0.02 DBMET02127 0.607 0.012 DBMET02128 0.578 0.016 DBMET02129 0.578 0.016 DBMET02130 0.47 0.041 DBMET02131 0.525 0.027 DBMET02132 | DBMET02128 | |
| 0.511 | 0.005 | 0.543 | Interferon gamma antagonist | 0.506 0.006 DBMET02127 0.498 0.006 DBMET02128 0.543 0.004 DBMET02129 0.543 0.004 DBMET02130 0.476 0.007 DBMET02131 0.525 0.005 DBMET02132 | DBMET02130 | |
| 0.502 | 0.002 | 0.775 | Androgen agonist | 0.384 0.003 DBMET02127 0.438 0.002 DBMET02128 0.452 0.002 DBMET02129 0.452 0.002 DBMET02130 0.775 0.001 DBMET02131 0.444 0.002 DBMET02132 | DBMET02131 | |
| 0.474 | 0.001 | 0.474 | 5-Alpha-reductase inhibitor | 0.409 0.002 DBMET02127 0.435 0.002 DBMET02128 0.365 0.002 DBMET02129 0.365 0.002 DBMET02130 0.405 0.002 DBMET02131 0.382 0.002 DBMET02132 | ||
| 0.479 | 0.017 | 0.705 | Nitric oxide antagonist | 0.482 0.017 DBMET02127 0.471 0.018 DBMET02128 0.492 0.016 DBMET02129 0.492 0.016 DBMET02130 0.705 0.005 DBMET02131 0.473 0.018 DBMET02132 | DBMET02131 | |
| 0.457 | 0.004 | 0.597 | Estrogen agonist | 0.308 0.005 DBMET02127 0.288 0.005 DBMET02128 0.309 0.005 DBMET02129 0.309 0.005 DBMET02130 0.597 0.003 DBMET02131 0.352 0.004 DBMET02132 | DBMET02131 | |
| 0.451 | 0.007 | 0.476 | Sodium/bile acid cotransporter inhibitor | 0.429 0.01 DBMET02127 0.44 0.009 DBMET02128 0.476 0.005 DBMET02129 0.476 0.005 DBMET02130 0.467 0.005 DBMET02131 0.45 0.007 DBMET02132 | DBMET02130 | |
| 0.425 | 0.003 | 0.482 | Mineralocorticoid receptor antagonist | 0.146 0.005 DBMET02127 0.112 0.007 DBMET02128 0.086 0.01 DBMET02129 0.086 0.01 DBMET02130 0.482 0.003 DBMET02131 0.164 0.005 DBMET02132 | DBMET02131 | |
| 0.417 | 0.002 | 0.417 | 5-Alpha-reductase 1 inhibitor | 0.293 0.002 DBMET02127 0.36 0.002 DBMET02128 0.163 0.003 DBMET02129 0.163 0.003 DBMET02130 0.328 0.002 DBMET02131 0.254 0.002 DBMET02132 | ||
| 0.405 | 0.013 | 0.468 | Diuretic | 0.254 0.03 DBMET02127 0.331 0.018 DBMET02128 0.169 0.062 DBMET02129 0.169 0.062 DBMET02130 0.468 0.009 DBMET02131 0.37 0.015 DBMET02132 | DBMET02131 | |
| 0.392 | 0.017 | 0.43 | P-glycoprotein inhibitor | 0.43 0.013 DBMET02127 0.356 0.02 DBMET02128 0.417 0.014 DBMET02129 0.417 0.014 DBMET02130 0.281 0.033 DBMET02131 0.29 0.031 DBMET02132 | DBMET02127 | |
| 0.414 | 0.04 | 0.445 | Caspase 3 stimulant | 0.367 0.054 DBMET02127 0.362 0.055 DBMET02128 0.445 0.031 DBMET02129 0.445 0.031 DBMET02130 0.419 0.039 DBMET02131 0.289 0.084 DBMET02132 | DBMET02130 | |
| 0.37 | 0.001 | 0.572 | Anabolic | 0.312 0.001 DBMET02127 0.572 0.001 DBMET02128 0.401 0.001 DBMET02129 0.401 0.001 DBMET02130 0.507 0.001 DBMET02131 0.297 0.001 DBMET02132 | DBMET02128 | |
| 0.37 | 0.002 | 0.37 | 5-Alpha-reductase 2 inhibitor | 0.29 0.002 DBMET02127 0.348 0.002 DBMET02128 0.208 0.003 DBMET02129 0.208 0.003 DBMET02130 0.339 0.002 DBMET02131 0.285 0.002 DBMET02132 | ||
| 0.362 | 0.003 | 0.491 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.248 0.003 DBMET02127 0.386 0.003 DBMET02128 0.384 0.003 DBMET02129 0.384 0.003 DBMET02130 0.491 0.002 DBMET02131 0.177 0.004 DBMET02132 | DBMET02131 | |
| 0.35 | 0.005 | 0.602 | Estrogen antagonist | 0.24 0.009 DBMET02127 0.207 0.012 DBMET02128 0.228 0.01 DBMET02129 0.228 0.01 DBMET02130 0.602 0.004 DBMET02131 0.318 0.005 DBMET02132 | DBMET02131 | |
| 0.322 | 0.002 | 0.322 | Glucocorticoid antagonist | 0.223 0.003 DBMET02127 0.16 0.004 DBMET02128 0.168 0.004 DBMET02129 0.168 0.004 DBMET02130 0.277 0.003 DBMET02131 0.249 0.003 DBMET02132 | ||
| 0.344 | 0.025 | 0.48 | Anesthetic general | 0.39 0.018 DBMET02127 0.373 0.02 DBMET02128 0.473 0.01 DBMET02129 0.473 0.01 DBMET02130 0.456 0.011 DBMET02131 0.48 0.009 DBMET02132 | DBMET02132 | |
| 0.317 | 0.003 | 0.379 | Aldosterone antagonist | 0.085 0.01 DBMET02127 0.045 0.037 DBMET02128 0.073 0.013 DBMET02129 0.073 0.013 DBMET02130 0.379 0.002 DBMET02131 0.171 0.005 DBMET02132 | DBMET02131 | |
| 0.312 | 0.001 | 0.313 | Arachidonic acid antagonist | 0.313 0.001 DBMET02127 0.29 0.002 DBMET02128 0.31 0.001 DBMET02129 0.31 0.001 DBMET02130 0.28 0.003 DBMET02131 0.305 0.002 DBMET02132 | DBMET02127 | |
| 0.357 | 0.053 | 0.421 | Apoptosis antagonist | 0.332 0.065 DBMET02127 0.354 0.054 DBMET02128 0.421 0.033 DBMET02129 0.421 0.033 DBMET02130 0.416 0.034 DBMET02131 0.286 0.095 DBMET02132 | DBMET02130 | |
| 0.347 | 0.066 | 0.645 | Cholesterol antagonist | 0.428 0.044 DBMET02127 0.6 0.019 DBMET02128 0.645 0.013 DBMET02129 0.645 0.013 DBMET02130 0.559 0.024 DBMET02131 0.47 0.037 DBMET02132 | DBMET02130 | |
| 0.288 | 0.033 | 0.365 | Hepatoprotectant | 0.325 0.023 DBMET02127 0.332 0.022 DBMET02128 0.365 0.017 DBMET02129 0.365 0.017 DBMET02130 0.32 0.024 DBMET02131 0.303 0.029 DBMET02132 | DBMET02130 | |
| 0.271 | 0.022 | 0.371 | Protein kinase stimulant | 0.206 0.039 DBMET02127 0.362 0.011 DBMET02128 0.371 0.01 DBMET02129 0.371 0.01 DBMET02130 0.272 0.021 DBMET02131 0.152 0.067 DBMET02132 | DBMET02130 | |
| 0.269 | 0.029 | 0.368 | Neurotrophic factor enhancer | 0.34 0.01 DBMET02127 0.33 0.012 DBMET02128 0.368 0.008 DBMET02129 0.368 0.008 DBMET02130 0.272 0.028 DBMET02131 0.368 0.008 DBMET02132 | DBMET02132 | |
| 0.29 | 0.065 | 0.436 | Antioxidant | 0.27 0.074 DBMET02127 0.271 0.073 DBMET02128 0.347 0.047 DBMET02129 0.347 0.047 DBMET02130 0.436 0.029 DBMET02131 0.281 0.069 DBMET02132 | DBMET02131 | |
| 0.276 | 0.053 | 0.44 | DNA synthesis inhibitor | 0.307 0.041 DBMET02127 0.333 0.034 DBMET02128 0.44 0.018 DBMET02129 0.44 0.018 DBMET02130 0.342 0.032 DBMET02131 0.343 0.032 DBMET02132 | DBMET02130 | |
| 0.224 | 0.002 | 0.541 | Glucocorticoid agonist | 0.226 0.002 DBMET02127 0.137 0.002 DBMET02128 0.168 0.002 DBMET02129 0.168 0.002 DBMET02130 0.059 0.004 DBMET02131 0.541 0.001 DBMET02132 | DBMET02132 | |
| 0.249 | 0.027 | 0.454 | NOS3 expression enhancer | 0.119 0.118 DBMET02128 0.174 0.053 DBMET02129 0.174 0.053 DBMET02130 0.454 0.006 DBMET02131 0.184 0.048 DBMET02132 | DBMET02131 | |
| 0.247 | 0.025 | 0.258 | Antipruritic | 0.258 0.022 DBMET02127 0.243 0.027 DBMET02128 0.239 0.028 DBMET02129 0.239 0.028 DBMET02130 0.13 0.122 DBMET02131 0.243 0.027 DBMET02132 | DBMET02127 | |
| 0.285 | 0.064 | 0.339 | DNA damaging | 0.255 0.078 DBMET02127 0.198 0.117 DBMET02128 0.271 0.07 DBMET02129 0.271 0.07 DBMET02130 0.339 0.044 DBMET02131 0.274 0.069 DBMET02132 | DBMET02131 | |
| 0.22 | 0.017 | 0.277 | Farnesoid X receptor antagonist | 0.214 0.018 DBMET02127 0.202 0.021 DBMET02128 0.277 0.008 DBMET02129 0.277 0.008 DBMET02130 0.268 0.009 DBMET02131 0.237 0.013 DBMET02132 | DBMET02130 | |
| 0.205 | 0.004 | 0.76 | Estradiol 17 beta-dehydrogenase inhibitor | 0.082 0.013 DBMET02127 0.099 0.01 DBMET02128 0.108 0.01 DBMET02129 0.108 0.01 DBMET02130 0.76 0.001 DBMET02131 0.246 0.004 DBMET02132 | DBMET02131 | |
| 0.196 | 0.003 | 0.347 | RNA-directed RNA polymerase stimulant | 0.261 0.002 DBMET02127 0.238 0.003 DBMET02128 0.18 0.003 DBMET02129 0.18 0.003 DBMET02130 0.347 0.002 DBMET02131 0.319 0.002 DBMET02132 | DBMET02131 | |
| 0.203 | 0.019 | 0.256 | Microtubule formation inhibitor | 0.229 0.014 DBMET02127 0.251 0.008 DBMET02128 0.256 0.007 DBMET02129 0.256 0.007 DBMET02130 0.252 0.008 DBMET02131 0.221 0.016 DBMET02132 | DBMET02130 | |
| 0.185 | 0.005 | 0.344 | Estrogen receptor beta agonist | 0.161 0.006 DBMET02127 0.142 0.008 DBMET02128 0.146 0.007 DBMET02129 0.146 0.007 DBMET02130 0.344 0.004 DBMET02131 0.214 0.004 DBMET02132 | DBMET02131 | |
| 0.2 | 0.021 | 0.239 | Antineoplastic antibiotic | 0.218 0.018 DBMET02127 0.231 0.016 DBMET02128 0.239 0.015 DBMET02129 0.239 0.015 DBMET02130 0.147 0.031 DBMET02131 0.235 0.016 DBMET02132 | DBMET02130 | |
| 0.2 | 0.026 | 0.231 | Alkylator | 0.126 0.062 DBMET02127 0.187 0.03 DBMET02128 0.219 0.021 DBMET02129 0.219 0.021 DBMET02130 0.231 0.019 DBMET02131 0.135 0.055 DBMET02132 | DBMET02131 | |
| 0.182 | 0.009 | 0.516 | Estrogen receptor alpha antagonist | 0.121 0.018 DBMET02127 0.115 0.02 DBMET02128 0.154 0.011 DBMET02129 0.154 0.011 DBMET02130 0.516 0.003 DBMET02131 0.236 0.007 DBMET02132 | DBMET02131 | |
| 0.204 | 0.035 | 0.284 | Bone formation stimulant | 0.166 0.048 DBMET02127 0.179 0.042 DBMET02128 0.168 0.047 DBMET02129 0.168 0.047 DBMET02130 0.284 0.019 DBMET02131 0.166 0.048 DBMET02132 | DBMET02131 | |
| 0.184 | 0.017 | 0.293 | Pregnane X receptor agonist | 0.188 0.014 DBMET02127 0.227 0.006 DBMET02128 0.189 0.014 DBMET02129 0.189 0.014 DBMET02130 0.293 0.004 DBMET02131 0.185 0.016 DBMET02132 | DBMET02131 | |
| 0.171 | 0.012 | 0.338 | Estrogen receptor beta antagonist | 0.147 0.016 DBMET02127 0.137 0.02 DBMET02128 0.137 0.02 DBMET02129 0.137 0.02 DBMET02130 0.338 0.005 DBMET02131 0.231 0.008 DBMET02132 | DBMET02131 | |
| 0.153 | 0.001 | 0.153 | Progesterone receptor A antagonist | 0.055 0.002 DBMET02127 0.016 0.004 DBMET02128 0.024 0.003 DBMET02129 0.024 0.003 DBMET02130 0.045 0.002 DBMET02131 0.04 0.002 DBMET02132 | ||
| 0.172 | 0.021 | 0.217 | Antineoplastic alkaloid | 0.213 0.01 DBMET02127 0.212 0.011 DBMET02128 0.205 0.013 DBMET02129 0.205 0.013 DBMET02130 0.137 0.031 DBMET02131 0.217 0.009 DBMET02132 | DBMET02132 | |
| 0.15 | 0.002 | 0.153 | Lipocortins synthesis agonist | 0.153 0.002 DBMET02127 0.133 0.002 DBMET02128 0.143 0.002 DBMET02129 0.143 0.002 DBMET02130 0.112 0.004 DBMET02131 0.143 0.002 DBMET02132 | DBMET02127 | |
| 0.149 | 0.005 | 0.322 | Estrogen receptor alpha agonist | 0.106 0.008 DBMET02127 0.115 0.007 DBMET02128 0.118 0.007 DBMET02129 0.118 0.007 DBMET02130 0.322 0.003 DBMET02131 0.211 0.004 DBMET02132 | DBMET02131 | |
| 0.146 | 0.004 | 0.156 | Estrone sulfatase inhibitor | 0.107 0.004 DBMET02127 0.075 0.005 DBMET02128 0.06 0.006 DBMET02129 0.06 0.006 DBMET02130 0.156 0.003 DBMET02131 0.14 0.004 DBMET02132 | DBMET02131 | |
| 0.205 | 0.067 | 0.292 | Non-steroidal antiinflammatory agent | 0.292 0.03 DBMET02127 0.288 0.031 DBMET02128 0.27 0.036 DBMET02129 0.27 0.036 DBMET02130 0.202 0.069 DBMET02132 | DBMET02127 | |
| 0.185 | 0.048 | 0.262 | Melanin inhibitor | 0.153 0.078 DBMET02127 0.262 0.027 DBMET02128 0.179 0.052 DBMET02129 0.179 0.052 DBMET02130 0.241 0.03 DBMET02131 0.175 0.055 DBMET02132 | DBMET02128 | |
| 0.149 | 0.015 | 0.309 | Keratolytic | 0.106 0.027 DBMET02127 0.197 0.009 DBMET02128 0.159 0.013 DBMET02129 0.159 0.013 DBMET02130 0.309 0.004 DBMET02131 0.094 0.035 DBMET02132 | DBMET02131 | |
| 0.137 | 0.009 | 0.184 | Na+ K+ transporting ATPase inhibitor | 0.159 0.004 DBMET02127 0.184 0.003 DBMET02128 0.182 0.003 DBMET02129 0.182 0.003 DBMET02130 0.164 0.004 DBMET02131 0.168 0.004 DBMET02132 | DBMET02128 | |
| 0.142 | 0.014 | 0.142 | Ornithine decarboxylase inhibitor | 0.134 0.017 DBMET02127 0.134 0.017 DBMET02128 0.128 0.021 DBMET02129 0.128 0.021 DBMET02130 0.089 0.057 DBMET02131 0.108 0.036 DBMET02132 | ||
| 0.159 | 0.04 | 0.359 | Cholesterol synthesis inhibitor | 0.225 0.022 DBMET02127 0.315 0.01 DBMET02128 0.359 0.006 DBMET02129 0.359 0.006 DBMET02130 0.226 0.021 DBMET02131 0.251 0.018 DBMET02132 | DBMET02130 | |
| 0.173 | 0.054 | 0.173 | Lipid peroxidase inhibitor | 0.126 0.088 DBMET02128 0.138 0.077 DBMET02129 0.138 0.077 DBMET02130 0.162 0.06 DBMET02131 | ||
| 0.204 | 0.092 | 0.289 | Angiogenesis stimulant | 0.156 0.119 DBMET02127 0.177 0.107 DBMET02128 0.289 0.053 DBMET02129 0.289 0.053 DBMET02130 0.283 0.056 DBMET02131 0.166 0.113 DBMET02132 | DBMET02130 | |
| 0.116 | 0.006 | 0.172 | Potassium channel Kv1.3 blocker | 0.151 0.004 DBMET02127 0.172 0.004 DBMET02128 0.147 0.004 DBMET02129 0.147 0.004 DBMET02130 0.117 0.006 DBMET02131 0.15 0.004 DBMET02132 | DBMET02128 | |
| 0.237 | 0.134 | 0.352 | Interleukin 2 agonist | 0.249 0.119 DBMET02127 0.339 0.05 DBMET02128 0.332 0.054 DBMET02129 0.332 0.054 DBMET02130 0.352 0.045 DBMET02131 0.283 0.087 DBMET02132 | DBMET02131 | |
| 0.116 | 0.014 | 0.238 | Glycine receptor agonist | 0.107 0.017 DBMET02127 0.093 0.026 DBMET02128 0.238 0.003 DBMET02129 0.238 0.003 DBMET02130 0.134 0.009 DBMET02131 0.099 0.021 DBMET02132 | DBMET02130 | |
| 0.119 | 0.02 | 0.185 | Bile acid receptor antagonist | 0.111 0.03 DBMET02127 0.117 0.022 DBMET02128 0.178 0.005 DBMET02129 0.178 0.005 DBMET02130 0.185 0.005 DBMET02131 0.117 0.022 DBMET02132 | DBMET02131 | |
| 0.146 | 0.052 | 0.171 | Ca2+-transporting ATPase inhibitor | 0.157 0.029 DBMET02127 0.156 0.029 DBMET02128 0.171 0.012 DBMET02129 0.171 0.012 DBMET02130 0.136 0.091 DBMET02131 0.149 0.045 DBMET02132 | DBMET02130 | |
| 0.207 | 0.114 | 0.345 | Interleukin agonist | 0.223 0.1 DBMET02127 0.334 0.034 DBMET02128 0.345 0.03 DBMET02129 0.345 0.03 DBMET02130 0.296 0.05 DBMET02131 0.172 0.147 DBMET02132 | DBMET02130 | |
| 0.091 | 0.002 | 0.091 | Corticosteroid-like | 0.079 0.002 DBMET02127 0.058 0.003 DBMET02128 0.069 0.002 DBMET02129 0.069 0.002 DBMET02130 0.05 0.003 DBMET02131 0.069 0.002 DBMET02132 | ||
| 0.11 | 0.03 | 0.144 | Inducible nitric-oxide synthase inhibitor | 0.089 0.049 DBMET02127 0.081 0.06 DBMET02128 0.144 0.017 DBMET02131 | DBMET02131 | |
| 0.174 | 0.095 | 0.285 | Growth factor agonist | 0.261 0.027 DBMET02127 0.273 0.023 DBMET02128 0.178 0.089 DBMET02129 0.178 0.089 DBMET02130 0.228 0.042 DBMET02131 0.285 0.019 DBMET02132 | DBMET02132 | |
| 0.189 | 0.111 | 0.646 | Aldehyde oxidase inhibitor | 0.16 0.131 DBMET02128 0.164 0.128 DBMET02129 0.164 0.128 DBMET02130 0.646 0.013 DBMET02131 0.308 0.064 DBMET02132 | DBMET02131 | |
| 0.072 | 0.005 | 0.103 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.087 0.005 DBMET02127 0.052 0.008 DBMET02128 0.103 0.004 DBMET02129 0.103 0.004 DBMET02130 0.086 0.005 DBMET02131 0.072 0.005 DBMET02132 | DBMET02130 | |
| 0.142 | 0.077 | 0.203 | Adenylate cyclase stimulant | 0.142 0.076 DBMET02127 0.186 0.021 DBMET02128 0.203 0.012 DBMET02129 0.203 0.012 DBMET02130 0.183 0.023 DBMET02131 0.133 0.094 DBMET02132 | DBMET02130 | |
| 0.079 | 0.016 | 0.09 | Heme oxygenase stimulant | 0.076 0.018 DBMET02127 0.072 0.023 DBMET02128 0.072 0.023 DBMET02129 0.072 0.023 DBMET02130 0.09 0.01 DBMET02131 0.086 0.012 DBMET02132 | DBMET02131 | |
| 0.11 | 0.046 | 0.124 | Prolactin inhibitor | 0.105 0.051 DBMET02127 0.103 0.053 DBMET02128 0.124 0.036 DBMET02129 0.124 0.036 DBMET02130 | DBMET02130 | |
| 0.067 | 0.005 | 0.088 | Glucose-6-phosphate dehydrogenase inhibitor | 0.073 0.004 DBMET02127 0.063 0.006 DBMET02128 0.088 0.003 DBMET02129 0.088 0.003 DBMET02130 0.074 0.004 DBMET02131 0.085 0.004 DBMET02132 | DBMET02130 | |
| 0.097 | 0.035 | 0.161 | Glycine receptor antagonist | 0.081 0.055 DBMET02127 0.13 0.013 DBMET02129 0.13 0.013 DBMET02130 0.161 0.005 DBMET02131 0.125 0.015 DBMET02132 | DBMET02131 | |
| 0.113 | 0.051 | 0.14 | Toll-Like receptor 4 antagonist | 0.114 0.05 DBMET02127 0.14 0.027 DBMET02129 0.14 0.027 DBMET02130 0.119 0.044 DBMET02132 | DBMET02130 | |
| 0.099 | 0.039 | 0.129 | Transcription factor NF kappa B stimulant | 0.107 0.033 DBMET02127 0.115 0.028 DBMET02128 0.129 0.021 DBMET02129 0.129 0.021 DBMET02130 0.103 0.036 DBMET02131 0.1 0.039 DBMET02132 | DBMET02130 | |
| 0.061 | 0.003 | 0.061 | Progesterone receptor B antagonist | 0.048 0.003 DBMET02127 0.039 0.004 DBMET02128 0.039 0.004 DBMET02129 0.039 0.004 DBMET02130 0.051 0.003 DBMET02131 0.052 0.003 DBMET02132 | ||
| 0.119 | 0.062 | 0.133 | Monophenol monooxygenase inhibitor | 0.099 0.077 DBMET02127 0.119 0.062 DBMET02128 0.12 0.061 DBMET02129 0.12 0.061 DBMET02130 0.12 0.061 DBMET02131 0.133 0.054 DBMET02132 | DBMET02132 | |
| 0.06 | 0.008 | 0.147 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.033 0.021 DBMET02127 0.029 0.026 DBMET02128 0.052 0.01 DBMET02129 0.052 0.01 DBMET02130 0.147 0.004 DBMET02131 0.074 0.005 DBMET02132 | DBMET02131 | |
| 0.071 | 0.021 | 0.221 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.05 0.043 DBMET02129 0.05 0.043 DBMET02130 0.221 0.003 DBMET02131 0.095 0.011 DBMET02132 | DBMET02131 | |
| 0.065 | 0.02 | 0.087 | Pregnane X receptor antagonist | 0.068 0.017 DBMET02127 0.087 0.005 DBMET02128 0.062 0.027 DBMET02129 0.062 0.027 DBMET02130 0.074 0.01 DBMET02131 0.071 0.013 DBMET02132 | DBMET02128 | |
| 0.057 | 0.013 | 0.077 | Parathyroid hormone antagonist | 0.06 0.011 DBMET02127 0.065 0.009 DBMET02128 0.077 0.005 DBMET02129 0.077 0.005 DBMET02130 0.077 0.005 DBMET02131 0.068 0.008 DBMET02132 | DBMET02131 | |
| 0.059 | 0.016 | 0.066 | Microtubule stabilization | 0.064 0.01 DBMET02127 0.065 0.01 DBMET02128 0.066 0.009 DBMET02129 0.066 0.009 DBMET02130 0.055 0.021 DBMET02131 0.053 0.024 DBMET02132 | DBMET02130 | |
| 0.087 | 0.046 | 0.119 | Estrogen-related receptor beta agonist | 0.08 0.066 DBMET02128 0.097 0.029 DBMET02129 0.097 0.029 DBMET02130 0.119 0.01 DBMET02131 | DBMET02131 | |
| 0.177 | 0.139 | 0.235 | RNA-directed DNA polymerase inhibitor | 0.189 0.116 DBMET02127 0.184 0.125 DBMET02128 0.203 0.095 DBMET02129 0.203 0.095 DBMET02130 0.235 0.059 DBMET02131 0.205 0.092 DBMET02132 | DBMET02131 | |
| 0.139 | 0.107 | 0.178 | Interleukin 6 antagonist | 0.13 0.125 DBMET02127 0.139 0.108 DBMET02128 0.17 0.064 DBMET02129 0.17 0.064 DBMET02130 0.154 0.084 DBMET02131 0.178 0.056 DBMET02132 | DBMET02132 | |
| 0.026 | 0.001 | 0.054 | Transcortin receptor antagonist | 0.015 0.002 DBMET02127 0.009 0.003 DBMET02128 0.024 0.001 DBMET02129 0.024 0.001 DBMET02130 0.054 0.001 DBMET02131 0.039 0.001 DBMET02132 | DBMET02131 | |
| 0.062 | 0.039 | 0.171 | Beta tubulin antagonist | 0.171 0.01 DBMET02131 | DBMET02131 | |
| 0.029 | 0.008 | 0.054 | Vitamin D receptor antagonist | 0.032 0.006 DBMET02127 0.038 0.005 DBMET02128 0.049 0.004 DBMET02129 0.049 0.004 DBMET02130 0.054 0.004 DBMET02131 0.048 0.004 DBMET02132 | DBMET02131 | |
| 0.081 | 0.063 | 0.088 | T cell inhibitor | 0.079 0.071 DBMET02127 0.088 0.042 DBMET02128 0.087 0.044 DBMET02131 0.082 0.06 DBMET02132 | DBMET02128 | |
| 0.019 | 0.003 | 0.023 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.016 0.004 DBMET02127 0.015 0.005 DBMET02128 0.012 0.01 DBMET02129 0.012 0.01 DBMET02130 0.023 0.002 DBMET02131 0.017 0.004 DBMET02132 | DBMET02131 | |
| 0.022 | 0.006 | 0.065 | Vitamin D receptor agonist | 0.03 0.004 DBMET02127 0.065 0.002 DBMET02128 0.065 0.002 DBMET02129 0.065 0.002 DBMET02130 0.033 0.003 DBMET02131 0.042 0.003 DBMET02132 | DBMET02130 | |
| 0.052 | 0.038 | 0.157 | Alpha tubulin antagonist | 0.157 0.009 DBMET02131 0.049 0.042 DBMET02132 | DBMET02131 | |
| 0.092 | 0.077 | 0.12 | Topoisomerase I inhibitor | 0.12 0.055 DBMET02129 0.12 0.055 DBMET02130 | DBMET02130 | |
| 0.07 | 0.057 | 0.089 | CDC25A inhibitor | 0.074 0.051 DBMET02127 0.083 0.04 DBMET02128 0.089 0.034 DBMET02129 0.089 0.034 DBMET02130 0.088 0.035 DBMET02131 0.077 0.046 DBMET02132 | DBMET02130 | |
| 0.06 | 0.048 | 0.072 | Nitric oxide donor | 0.059 0.05 DBMET02128 0.072 0.03 DBMET02129 0.072 0.03 DBMET02130 | DBMET02130 | |
| 0.025 | 0.014 | 0.463 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.463 0.001 DBMET02131 0.071 0.005 DBMET02132 | DBMET02131 | |
| 0.106 | 0.096 | 0.18 | Tubulin antagonist | 0.18 0.044 DBMET02131 | DBMET02131 | |
| 0.097 | 0.09 | 0.182 | DNA polymerase I inhibitor | 0.103 0.083 DBMET02127 0.138 0.056 DBMET02128 0.167 0.04 DBMET02129 0.167 0.04 DBMET02130 0.182 0.034 DBMET02131 0.16 0.044 DBMET02132 | DBMET02131 | |
| 0.15 | 0.151 | 0.204 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.203 0.07 DBMET02128 0.153 0.141 DBMET02129 0.153 0.141 DBMET02130 0.204 0.069 DBMET02131 | DBMET02131 | |
| 0.002 | 0.005 | 0.004 | Vitamin D-like | 0.004 0.003 DBMET02129 0.004 0.003 DBMET02130 | DBMET02130 | |
| 0.212 | 0.215 | 0.53 | Antibacterial | 0.289 0.143 DBMET02127 0.53 0.033 DBMET02128 0.367 0.093 DBMET02129 0.367 0.093 DBMET02130 0.306 0.131 DBMET02131 0.293 0.141 DBMET02132 | DBMET02128 | |
| 0.019 | 0.023 | 0.038 | CYP24 inhibitor | 0.027 0.012 DBMET02129 0.027 0.012 DBMET02130 0.038 0.007 DBMET02131 0.023 0.016 DBMET02132 | DBMET02131 | |
| 0.039 | 0.056 | 0.067 | Protein 50S ribosomal subunit inhibitor | 0.052 0.038 DBMET02127 0.065 0.027 DBMET02128 0.067 0.026 DBMET02129 0.067 0.026 DBMET02130 0.047 0.043 DBMET02132 | DBMET02130 | |
| 0.063 | 0.081 | 0.123 | Acetylcholine nicotinic antagonist | 0.123 0.029 DBMET02131 | DBMET02131 | |
| 0.075 | 0.096 | 0.087 | Thioredoxin inhibitor | 0.087 0.066 DBMET02127 | DBMET02127 | |
| 0.079 | 0.104 | 0.155 | Protein-tyrosine phosphatase 1B inhibitor | 0.09 0.089 DBMET02129 0.09 0.089 DBMET02130 0.155 0.044 DBMET02131 | DBMET02131 | |
| 0.111 | 0.136 | 0.181 | Growth hormone agonist | 0.129 0.109 DBMET02128 0.181 0.067 DBMET02129 0.181 0.067 DBMET02130 | DBMET02130 | |
| 0.103 | 0.129 | 0.187 | Neurotrophic factor | 0.124 0.088 DBMET02127 0.128 0.083 DBMET02128 0.187 0.034 DBMET02129 0.187 0.034 DBMET02130 0.128 0.083 DBMET02131 0.161 0.05 DBMET02132 | DBMET02130 | |
| 0.041 | 0.066 | 0.05 | Glucose-6-phosphate translocase inhibitor | 0.05 0.038 DBMET02129 0.05 0.038 DBMET02130 0.047 0.045 DBMET02132 | DBMET02130 | |
| 0.011 | 0.037 | 0.022 | Telomerase stimulant | 0.016 0.013 DBMET02128 0.022 0.006 DBMET02129 0.022 0.006 DBMET02130 0.02 0.008 DBMET02131 0.017 0.012 DBMET02132 | DBMET02130 | |
| 0.021 | 0.066 | 0.043 | HMG CoA reductase inhibitor | 0.043 0.011 DBMET02129 0.043 0.011 DBMET02130 | DBMET02130 | |
| 0.085 | 0.132 | 0.105 | Acetylcholinesterase inhibitor | 0.105 0.098 DBMET02131 | DBMET02131 | |
| 0.072 | 0.123 | 0.203 | Adenylate cyclase inhibitor | 0.122 0.066 DBMET02128 0.103 0.081 DBMET02129 0.103 0.081 DBMET02130 0.203 0.025 DBMET02131 | DBMET02131 | |
| 0.069 | 0.121 | 0.101 | ABCA1 expression enhancer | 0.085 0.075 DBMET02128 0.101 0.049 DBMET02129 0.101 0.049 DBMET02130 | DBMET02130 | |
| 0.023 | 0.076 | 0.037 | Tubulin agonist | 0.032 0.03 DBMET02128 0.037 0.018 DBMET02129 0.037 0.018 DBMET02130 0.033 0.027 DBMET02131 | DBMET02130 | |
| 0.033 | 0.088 | 0.051 | HIV-1 integrase (Strand Transfer) inhibitor | 0.051 0.049 DBMET02129 0.051 0.049 DBMET02130 | DBMET02130 | |
| 0.029 | 0.085 | 0.058 | Adenylate cyclase 1 inhibitor | 0.052 0.024 DBMET02129 0.052 0.024 DBMET02130 0.058 0.019 DBMET02131 | DBMET02131 | |
| 0.006 | 0.065 | 0.025 | Prostacyclin agonist | 0.016 0.011 DBMET02128 0.025 0.007 DBMET02129 0.025 0.007 DBMET02130 | DBMET02130 | |
| 0.104 | 0.165 | 0.215 | Psychostimulant | 0.156 0.111 DBMET02127 0.215 0.072 DBMET02128 0.165 0.104 DBMET02131 0.143 0.122 DBMET02132 | DBMET02128 | |
| 0.18 | 0.247 | 0.407 | Calcium channel activator | 0.302 0.09 DBMET02127 0.407 0.022 DBMET02128 0.294 0.098 DBMET02129 0.294 0.098 DBMET02130 0.277 0.116 DBMET02131 0.299 0.093 DBMET02132 | DBMET02128 | |
| 0.119 | 0.189 | 0.265 | Phospholipase C inhibitor | 0.137 0.135 DBMET02127 0.265 0.022 DBMET02129 0.265 0.022 DBMET02130 0.199 0.045 DBMET02131 0.171 0.072 DBMET02132 | DBMET02130 | |
| 0.022 | 0.096 | 0.039 | Liver X receptor alpha agonist | 0.037 0.035 DBMET02129 0.037 0.035 DBMET02130 0.039 0.031 DBMET02131 | DBMET02131 | |
| 0.019 | 0.094 | 0.055 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.055 0.025 DBMET02132 | DBMET02132 | |
| 0.117 | 0.196 | 0.166 | Free radical scavenger | 0.156 0.138 DBMET02129 0.156 0.138 DBMET02130 0.166 0.127 DBMET02131 | DBMET02131 | |
| 0.016 | 0.096 | 0.032 | ATP citrate lysase inhibitor | 0.032 0.021 DBMET02131 | DBMET02131 | |
| 0.115 | 0.195 | 0.312 | Immunostimulant | 0.169 0.14 DBMET02127 0.26 0.092 DBMET02128 0.312 0.075 DBMET02129 0.312 0.075 DBMET02130 0.241 0.1 DBMET02131 0.19 0.127 DBMET02132 | DBMET02130 | |
| 0.02 | 0.1 | 0.043 | GABA uptake inhibitor | 0.043 0.022 DBMET02132 | DBMET02132 | |
| 0.02 | 0.105 | 0.031 | Glutamate (mGluR3) agonist | 0.031 0.026 DBMET02129 0.031 0.026 DBMET02130 | DBMET02130 | |
| 0.094 | 0.188 | 0.239 | Platelet adhesion inhibitor | 0.136 0.124 DBMET02127 0.185 0.079 DBMET02128 0.239 0.053 DBMET02129 0.239 0.053 DBMET02130 0.143 0.114 DBMET02131 | DBMET02130 | |
| 0.098 | 0.201 | 0.169 | Antimitotic | 0.169 0.105 DBMET02128 | DBMET02128 | |
| 0.045 | 0.151 | 0.069 | Glutamate (mGluR6) antagonist | 0.063 0.057 DBMET02128 0.064 0.054 DBMET02129 0.064 0.054 DBMET02130 0.069 0.043 DBMET02131 | DBMET02131 | |
| 0.068 | 0.176 | 0.206 | Hedgehog signaling inhibitor | 0.206 0.01 DBMET02131 | DBMET02131 | |
| 0.05 | 0.166 | 0.166 | Expectorant | 0.105 0.063 DBMET02128 0.166 0.029 DBMET02129 0.166 0.029 DBMET02130 | DBMET02130 | |
| 0.029 | 0.15 | 0.07 | Acetyl-CoA transferase 2 inhibitor | 0.07 0.017 DBMET02129 0.07 0.017 DBMET02130 | DBMET02130 | |
| 0.13 | 0.25 | 0.183 | Transcription factor STAT3 inhibitor | 0.183 0.159 DBMET02131 | DBMET02131 | |
| 0.154 | 0.278 | 0.198 | 5 Hydroxytryptamine uptake stimulant | 0.198 0.155 DBMET02131 0.187 0.18 DBMET02132 | DBMET02131 | |
| 0.052 | 0.187 | 0.111 | Nitric-oxide synthase inhibitor | 0.111 0.045 DBMET02131 | DBMET02131 | |
| 0.055 | 0.191 | 0.204 | Amylase inhibitor | 0.16 0.059 DBMET02129 0.16 0.059 DBMET02130 0.204 0.043 DBMET02131 | DBMET02131 | |
| 0.017 | 0.153 | 0.038 | Estrogen-related receptor beta antagonist | 0.038 0.014 DBMET02131 | DBMET02131 | |
| 0.135 | 0.276 | 0.335 | Antithrombotic | 0.202 0.174 DBMET02127 0.322 0.075 DBMET02128 0.335 0.07 DBMET02129 0.335 0.07 DBMET02130 0.208 0.168 DBMET02131 | DBMET02130 | |
| 0.042 | 0.19 | 0.08 | Opioid kappa receptor antagonist | 0.08 0.058 DBMET02132 | DBMET02132 | |
| 0.067 | 0.218 | 0.144 | Protein-tyrosine phosphatase inhibitor | 0.144 0.084 DBMET02131 | DBMET02131 | |
| 0.053 | 0.206 | 0.108 | Acetylcholine antagonist | 0.108 0.082 DBMET02131 | DBMET02131 | |
| 0.054 | 0.207 | 0.141 | Mucolytic | 0.099 0.079 DBMET02128 0.141 0.038 DBMET02129 0.141 0.038 DBMET02130 | DBMET02130 | |
| 0.053 | 0.208 | 0.109 | Cholinergic antagonist | 0.109 0.084 DBMET02131 | DBMET02131 | |
| 0.065 | 0.221 | 0.138 | Interleukin 4 antagonist | 0.115 0.093 DBMET02128 0.138 0.062 DBMET02129 0.138 0.062 DBMET02130 | DBMET02130 | |
| 0.115 | 0.284 | 0.201 | Gastrin inhibitor | 0.201 0.148 DBMET02127 | DBMET02127 | |
| 0.058 | 0.23 | 0.12 | Cyclooxygenase 3 inhibitor | 0.12 0.078 DBMET02128 | DBMET02128 | |
| 0.015 | 0.188 | 0.037 | Hedgehog signaling activator | 0.037 0.005 DBMET02129 0.037 0.005 DBMET02130 0.03 0.012 DBMET02131 0.028 0.017 DBMET02132 | DBMET02130 | |
| 0.119 | 0.309 | 0.315 | Vasodilator, coronary | 0.256 0.129 DBMET02128 0.315 0.076 DBMET02129 0.315 0.076 DBMET02130 | DBMET02130 | |
| 0.103 | 0.31 | 0.163 | 5 Hydroxytryptamine release stimulant | 0.163 0.162 DBMET02131 | DBMET02131 | |
| 0.071 | 0.281 | 0.266 | Hypolipemic | 0.187 0.104 DBMET02128 0.266 0.061 DBMET02129 0.266 0.061 DBMET02130 | DBMET02130 | |
| 0.006 | 0.269 | 0.041 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.041 0.02 DBMET02131 | DBMET02131 | |
| 0.061 | 0.363 | 0.206 | Vasodilator | 0.206 0.1 DBMET02129 0.206 0.1 DBMET02130 | DBMET02130 | |
| 0.048 | 0.378 | 0.211 | Platelet antagonist | 0.17 0.126 DBMET02128 0.211 0.093 DBMET02129 0.211 0.093 DBMET02130 | DBMET02130 | |
| 0.005 | 0.337 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 DBMET02128 | DBMET02128 | |
| 0.014 | 0.35 | 0.044 | Farnesyltransferase inhibitor | 0.044 0.034 DBMET02132 | DBMET02132 | |
| 0.077 | 0.443 | 0.219 | Vasodilator, peripheral | 0.219 0.155 DBMET02129 0.219 0.155 DBMET02130 | DBMET02130 | |
| 0.048 | 0.422 | 0.348 | Tumour necrosis factor alpha release inhibitor | 0.172 0.133 DBMET02127 0.348 0.038 DBMET02128 0.164 0.14 DBMET02129 0.164 0.14 DBMET02130 0.19 0.118 DBMET02132 | DBMET02128 | |
| 0.064 | 0.507 | 0.232 | Immunomodulator | 0.232 0.13 DBMET02129 0.232 0.13 DBMET02130 | DBMET02130 | |
| 0.029 | 0.499 | 0.174 | Interleukin antagonist | 0.174 0.101 DBMET02128 | DBMET02128 | |
| 0.084 | 0.719 | 0.367 | Calcium channel L-type activator | 0.367 0.105 DBMET02128 | DBMET02128 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |